Trailhead Biosystems Expands iPSC-Derived Portfolio with TrailBio® Hematopoietic Progenitor Cells

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Trailhead-Bio-Expands

More Like This

PR Newswire associated0

bit.bio Launches ioTracker Cells Range at SLAS 2025, Adding New Visualisation Functionality to Human iPSC-derived Cell Types

CRISPR-Ready ioGlutamatergic Neurons (Graphic: Business Wire)

bit.bio introduces first product in groundbreaking ioCRISPR-Ready Cells™ product range, paving the way for new advances in disease modelling and drug discovery

BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell

PR Newswire associated0

REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs

(Graphic: Business Wire)

PHC Unveils Prototype of LiCellGrow, New Cell Expansion System to Support Development of Cell and Gene Therapy Products Manufacturing Process

Controller and processor, Filter-less culture bag and reservoir/waste bags *Controller and other accessories sold separately, but all of them required for operating the system.

PHCbi Launches LiCellGrow™ Cell Expansion System to Support High-Quality and Efficient Production of Cell and Gene Therapies

bit.bio launches ioAstrocytes, advancing how scientists can model the human brain (Photo: Business Wire)

bit.bio Launches ioAstrocytes, Advancing How Scientists Can Model the Human Brain

Breakthrough in Patient-Derived Stem Cells for Therapeutic Regenerative Medicine